References
- Shibata T, Nagata K, Kobayashi Y. Cutting edge: A critical role of nitric oxide in preventing inflammation upon apo cell clearance. J Immunol 2007; 179(6)3407–3411
- Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I. Immunosuppressive effects of apo cells. Nature 1997; 390: 350–351
- Munoz LE, Frey B, Pausch F, Baum W, Mueller RB, Brachvogel B, Poschl E, Rödel F, von der Mark K, Herrmann M, Gaipl US. The role of annexin A5 in the modulation of the immune response against dying and dead cells. Curr Med Chem 2007; 14(3)271–277
- Noessner E. Thermal stress-related modulation of tumor cell physiology and immune responses. Cancer Immunol Immunother 2006; 55(3)289–291
- Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apo. Blood 1994; 84(5)1415–1420
- Hagenhofer M, Germaier H, Hohenadl C, Rohwer P, Kalden JR, Herrmann M. UV-B irradiated cell lines execute programmed cell death in various forms. Apo 1998; 3(2)123–132
- Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apo by propidium iodide staining and flow cytometry. J Immunol Methods 1991; 139(2)271–279
- Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Perfettini JL, Castedo M, Mignot G, Panaretakis T, Casares N, Métivier D, Larochette N, van Endert P, Ciccosanti F, Piacentini M, Zitvogel L, Kroemer G. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 2007; 13(1)54–61
- Ludewig B, Ochsenbein AF, Odermatt B, Paulin D, Hengartner H, Zinkernagel RM. Immunotherapy with DC directed against tumor antigens shared with normal host cell results in severe autoimmune disease. J Exp Med 2000; 191(5)795–804
- Bianchi ME. DAMPs, PAMPs and alarmins: All we need to know about danger. J Leukoc Biol 2007; 81(1)1–5
- Klune JR, Dhupar R, Cardinal J, Billiar TR, Tsung A. HMGB1: Endogenous danger signaling. Mol Med 2008; 14(7–8)476–484
- Reines BP. Hypothesis. Bystanders or bad seeds? Many autoimmune-target cells may be transforming to cancer and signalling ‘danger’ to the immune system. Autoimmunity 2001; 33(2)121–134